The relationship of target organ damage and 24-hour ambulatory blood pressure monitoring with vitamin D receptor gene Fok-I polymorphism in essential hypertension

Kidney and Blood Pressure Research

Volumn 29, Issue 6, 2007, Pages 344-350

  Kulah, Eyup ^a   Dursun, Ahmet ^a   Acikgoz, Serefden ^a   Can, Murat ^a   Kargi, Sebnem ^a   Ilikhan, Sevil ^a   Bozdogan, Sevcan ^a  

^a ZONGULDAK KARAELMAS UNIVERSITY   (Turkey)

Author keywords

Blood pressure, ambulatory; Retinopathy; Target organ damage; Vitamin D receptor gene polymorphism

Indexed keywords

CYSTATIN C; VITAMIN D; VITAMIN D RECEPTOR;

ADULT; APA I GENE; ARTICLE; BLOOD PRESSURE MONITORING; BSM I GENE; CORRELATION ANALYSIS; ESSENTIAL HYPERTENSION; EVALUATION; FEMALE; FOK I GENE; GENE; GENETIC POLYMORPHISM; GENOTYPE; GLUCOSE TOLERANCE; HEREDITY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OBESITY; PHYSICAL EXAMINATION; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RETINA EXAMINATION; RETINOPATHY; TARGET ORGAN; URINALYSIS;

ADULT; BLOOD PRESSURE; BLOOD PRESSURE MONITORING, AMBULATORY; FEMALE; GENOTYPE; HUMANS; HYPERTENSION, RENAL; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; RECEPTORS, CALCITRIOL; RETINAL DISEASES;

EID: 33846419781     PISSN: 14204096     EISSN: None     Source Type: Journal    
DOI: 10.1159/000097409     Document Type: Article

References (33)

1. Ward R: Familial aggregation in genetic epidemiology of blood pressure in hypertension; in Laragh J, Brenner B (eds): Hypertension: Pathophysiology, Diagnosis and Management, ed 2. New York, Raven Press, 1995, pp 67-86.
2. Merke J, Milde P, Lewicka S, Hugel U, Klaus G, Mangelsdorf DJ, Haussler MR, Rauterberg EW, Ritz E: Identification and regulation of 1,25- dihydroxyvitamin D3 receptoractivity and biosynthesis of 1,25-dihydroxyvitamin D3. Studies in cultured bovine aortic endothelial cells and human dermal capillaries. J Clin Invest 1989;83:1903-1915.
3. 2 vitamin D3 receptors and actions in vascular smooth muscle cells in vitro. Calcif Tissue Int 1987;41:112-114.
4. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR, Pike JW, Shine J, O'Malley BW: Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 1988;85:3294-3298.
5. Gross C, Eccleshall TR, Malloy PJ, Villa ML, Marcus R, Feldman D: The presence of a polymorphism at the translation initiation site of the vitamin D receptor gene is associated with low bone mineral density in post-menopausal Mexican-American women. J Bone Miner Res 1996;11:1850-1855.
6. Arai H, Miyamoto K-I, Taketani Y, Yamamoto H, Iemori Y, Morita K, Tonai T, Nishisho T, Mori S, Takeda E: A vitamin D receptor gene polymorphism in the translation initiation codon: effect on protein activity and relation to bone mineral density in Japanese women. J Bone Miner Res 1997;12:915-921.
7. Ortlepp JR, Lauscher J, Hoffmann R, Hanrath P, Joost HG: The vitamin D receptor gene variant is associated with the prevalence of type 2 diabetes mellitus and coronary artery disease. Diabet Med 2001;18:842-845.
8. Ortlepp JR, von Korff A, Hanrath P, Zerres K, Hoffmann R: Vitamin D receptor gene polymorphism Bsm-I is not associated with the prevalence and severity of CAD in a large-scale angiographic cohort of 3441 patients. Eur J Clin Invest 2003;33:106-109.
9. Taverna MJ, Selam JL, Slama G: Association between a protein polymorphism in the start codon of the vitamin D receptor gene and severe diabetic retinopathy in C-peptide-negative type 1 diabetes. J Clin Endocrinol Metab 2005;90:4803-4808.
10. Muray S, Parisi E, Cardus A, Craver L, Fernandez E: Influence of vitamin D receptor gene polymorphisms and 25-hydroxyvitamin D on blood pressure in apparently healthy subjects. J Hypertens 2003;21:2069-2075.
11. Devereux RB, Casale PN, Kligfield P, Eisenberg RR, Miller D, Campo E, Alonso DR: Performance of primary and derived M-mode echocardiographic measurements for detection of left ventricular hypertrophy in necropsied subjects and in patients with systemic hypertension, mitral regurgitation and dilated cardiomyopathy. Am J Cardiol 1986;57:1388-1393.
12. Levy D, Garrison RJ, Savage DD, Kannel WB, Castelli WP: Prognostic implications of echocardiographically determined left ventricular mass in the Framingham Heart Study. N Engl J Med 1990;322:1561-1566.
13. Selvaraj P, Chandra G, Kurian SM, Reetha AM, Narayanan PR: Association of vitamin D receptor gene variants of Bsm-I, Apa-I and Fok-I polymorphisms with susceptibility or resistance to pulmonary tuberculosis. Curr Sci 2003;84:1564-1568.
14. Keith NM, Wagener HP, Barker NW: Some different types of essential hypertension: their course and prognosis. Am J Med Sci 1974;268:336-345.
15. Morrison NA, Qi JC, Tokita A, Kelly PJ, Crofths L, Nguyen TV, et al: Prediction of bone density from vitamin D receptor alleles. Nature 1994;367:284-287.
16. Chiu KC, Chuang LM, Yoon C: The vitamin D receptor polymorphism in the translation initiation codon is a risk factor for insulin resistance in glucose tolerant Caucasians. BMC Med Genet 2001;2:2.
17. Watanabe S, Okura T, Liu J, Miyoshi K, Fukuoka T, Hiwada K, et al: Serum cystatin-C level is a marker of end-organ damage in patients with essential hypertension. Hypertens Res 2003;26:895-899.
18. Luc G, Bard JM, Lesueur C, Arveiler D, Evans A, Amouyel P, Ferrieres J, Juhan-Vague I, Fruchart JC, Ducimetiere P; PRIME Study: Plasma cystatin-C and development of coronary heart disease: the PRIME Study. Atherosclerosis 2006;185:375-380.
19. Koenig W, Twardella D, Brenner H, Rothenbacher D: Plasma concentrations of cystatin-C in patients with coronary heart disease and risk for secondary cardiovascular events: More than a simply a marker of glomerular filtration rate. Clin Chem 2005;51:321-327.
20. Carlberg C: Current understanding of the function of the nuclear vitamin D receptor in response to its natural and synthetic ligands. Recent Results Cancer Res 2003;164:29-42.
21. Suzuki T, Sano Y, Kinoshita S: Effects of 1alpha, 25-dihydroxyvitamin D3 on Langerhans cell migration and corneal neovascularization in mice. Invest Ophthalmol Vis Sci 2000;41:154-158.
22. Xue ML, Zhu H, Thakur A, Willcox M: 1 Alpha, 25-dihydroxyvitamin D3 inhibits proinflammatory cytokine and chemokine expression in human corneal epithelial cells colonized with Pseudomonas aeruginosa. Immunol Cell Biol 2002;80:340-345.
23. Aksoy H, Akcay F, Kurtul N, Baykal O, Avci B: Serum 1,25 dihydroxy vitamin D (1,25(OH)2D3), 25 hydroxy vitamin D (25(OH)D) and parathormone levels in diabetic retinopathy. Clin Biochem 2000;33:47-51.
24. Kristal-Boneh E, Froom P, Harari G, Ribak J: Association of calcitriol and blood pressure in normotensive men. Hypertension 1997;30:1289-1294.
25. Burgess ED, Hawkins RG, Watanabe M: Interaction of 1,25-dihydroxyvitamin D and plasma renin activity in high renin essential hypertension. Am J Hypertens 1990;3:903-905.
26. Lind L, Wengle B, Wide L, Ljunghall S: Reduction of blood pressure during long-term treatment with active vitamin D (alphacalcidol) is dependent on plasma renin activity and calcium status. A double-blind, placebo-controlled study. Am J Hypertens 1989;2:20-25.
27. Park CW, Oh YS, Shin YS, Kim CM, Kim YS, Kim SY, Choi EJ, Chang YS, Bang BK: Intravenous calcitriol regresses myocardial hypertrophy in hemodialysis patients with secondary hyperparathyroidism. Am J Kidney Dis 1999;33:73-81.
28. Schreiner DS, Jande SS, Lawson DE: Target cells of vitamin D in the vertebrate retina. Acta Anat (Basel) 1985;121:153-162.
29. Ban Y, Taniyama M, Yanagawa T, Yamada S, Maruyama T, Kasuga A, Ban Y: Vitamin D receptor initiation codon polymorphism influences genetic susceptibility to type 1 diabetes mellitus in the Japanese population. BMC Med Genet 2001;2:7.
30. Ogunkolade BW, Boucher BJ, Prahl JM, Bustin SA, Burrin JM, Noonan K, North BV, Mannan N, McDermott MF, DeLuca HF, Hitman GA: Vitamin D receptor (VDR) mRNA and VDR protein levels in relation to vitamin D status, insulin secretory capacity, and VDR genotype in Bangladeshi Asians. Diabetes 2002;51:2294-2300.
31. Chang JM, Kuo MC, Kuo HT, Hwang SJ, Tsai JC, Chen HC, Lai YH: 1-Alpha,25-dihydroxyvitamin D3 regulates inducible nitric oxide synthase messenger RNA expression and nitric oxide release in macrophage-like RAW 264.7 cells. J Lab Clin Med 2004;143:14-22.
32. Mantell DJ, Owens PE, Bundred NJ, Mawer EB, Canfield AE: 1 Alpha,25-dihydroxyvitamin D(3) inhibits angiogenesis in vitro and in vivo. Circ Res 2000;87:214-220.
33. Sprenger CC, Peterson A, Lance R, Ware JL, Drivdahl RH, Plymate SR: Regulation of proliferation of prostate epithelial cells by 1,25- dihydroxyvitamin D3 is accompanied by an increase in insulin-like growth factor binding protein-3. J Endocrinol 2001;170:609-618.